Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Neoplasms 3 Lymphoma 3 Preleukemia 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Lymphoproliferative Disorders 2 Lymphatic Diseases 2 Leukemia, Myeloid, Acute 2 Leukemia, Myeloid 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphoid 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Leukemia, B-Cell 2 Leukemia 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hematologic Diseases 2 Esophageal Neoplasms 2 Bone Marrow Diseases 2 Sarcoma 1 Primary Myelofibrosis 1 Pathologic Complete Response 1 Osteosarcoma 1 Neoplasms, Second Primary 1 Neoplasms, Plasma Cell 1

Interventions

Diathermy 6 Radiotherapy 2 Surgical Procedures, Operative 1 Solutions 1 Saline Solution 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Immunotherapy 1 Ifosfamide 1 Hyperthermia, Induced 1 Hydrogen Peroxide 1 Doxorubicin 1 Dacarbazine 1 Cryotherapy 1 Carboplatin 1 AC protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperthermia × Patient Reported Outcome Measures × 1 year × Clear all

NCT06452485 2025-10-06

RT-HYPE

Amsterdam UMC, location VUmc

Hyperthermia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡